BRIGHAM & WOMENS HOSPITAL INC

• NATIONAL JEWISH HEALTH

  UEI VLQKFEEJ3NE9

  $4.1M

  Subcontractor to this prime · 2 sub-awards · latest Nov 20, 2024

  • National Institutes of Health
  • “BWH INVESTIGATORS WILL PARTICIPATE IN TASK A FOR ALL FIVE YEARS OF THE COPDGENE. PHASE 4 PROJECT AND WILL PROVIDE KEY CONTRIBUTIONS TO BOTH SPECIFIC AIMS OF THE TECHNICAL PROPOSAL. BWH WILL LEAD THE BWH COMPONENT OF THE COPDGENE ADMINISTRATIVE CENTER.”
  • “THE SUB PI AND OTHER BWH INVESTIGATORS WILL PARTICIPATE IN TASK A FOR ALL FIVE YEARS OF THE COPDGENE PHASE 4 PROJECT AND WILL PROVIDE KEY CONTRIBUTIONS TO BOTH SPECIFIC AIMS OF THE TECHNICAL PROPOSAL. HE WILL LEAD THE BWH COMPONENT OF THE COPDGENE ADMINISTRATIVE CENTER AS WELL AS THE GENETIC ANALYSIS CENTER. THE OTHER BWH INVESTIGATOR WILL DIRECT THE BIOINFORMATICS CENTER, WHICH WILL PERFORM OMICS DATA ANALYSIS WITH STATISTICAL, MACHINE LEARNING, AND NETWORK APPROACHES. SAN JOSE ESTEPAR WILL LEAD THE BWH COMPONENT OF THE COPDGENE IMAGING CENTER, WHICH WILL FOCUS ON LOCAL EMPHYSEMA PROGRESSION AND COMORBIDITY (CARDIAC, PULMONARY VASCULAR, AND PECTORALIS MUSCLE) MEASURES IN COPDGENE CT SCANS. NWH INVESTIGATORS WILL CONTINUE TO CO-LEAD THE COPDGENE SUBTYPING CENTER. THE COPDGENE BIOREPOSITORY STAFF AT BWH WILL WORK WITH BWH INVESTIGATORS TO PROVIDE QUALITY-CONTROLLED GENOMIC AND MOLECULAR DATA FROM COPDGENE BIOSPECIMENS COLLECTED DURING ALL STUDY VISITS. THE LEAD PI AND THE BWH CO-INVESTIGATORS WILL PARTICIPATE IN MULTIPLE WEEKLY CALLS AND REGULAR COPDGENE INVESTIGATOR MEETINGS TO DISCUSS TASK A ACTIVITIES.”
• INTERNATIONAL AIDS VACCINE INITIATIVE INC.

  UEI ZEJBC8JQM3P5

  $740.6K

  Subcontractor to this prime · 1 sub-award · latest Apr 28, 2026

  • Office of Assistant Secretary for Preparedness and Response
  • “C109 PHASE 1 SUDV CTA”

• THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

  UEI F4N1QNPB95M4

  $119K

  Subcontracted by this company · 1 sub-award · latest Jul 6, 2026

  • National Institutes of Health
  • “THIS STATEMENT OF WORK DEFINES THE RESPONSIBILITIES OF DR. PURCELL, THE COLUMBIA UNIVERSITY IRVING MEDICAL CENTER MULTIPLE PRINCIPAL INVESTIGATOR (MPI) FOR THE NATIONAL SLEEP RESEARCH RESOURCE (NSRR). DR. PURCELL WILL PROVIDE SCIENTIFIC LEADERSHIP AND TECHNICAL IMPLEMENTATION FOCUSED ON LARGE-SCALE EEG/PSG SIGNAL PROCESSING, DATA HARMONIZATION, QUALITY CONTROL, AND DEVELOPMENT OF REPRODUCIBLE ANALYTIC RESOURCES TO SUPPORT POPULATION-LEVEL SLEEP RESEARCH, AND DATA SHARING ACTIVITIES OF THE NSRR. SPECIFIC ACTIVITIES WILL INCLUDE DEVELOPMENT AND VALIDATION OF SCALABLE PIPELINES FOR FEATURE EXTRACTION AND QUANTITATIVE SLEEP METRICS; HARMONIZATION OF SIGNAL FORMATS, ANNOTATIONS, AND DERIVED VARIABLES ACROSS CONTRIBUTING COHORTS; IMPLEMENTATION OF AUTOMATED AND SEMI-AUTOMATED SIGNAL QUALITY CONTROL PROCEDURES; INTEGRATION OF ANALYTIC WORKFLOWS INTO NSRR INFRASTRUCTURE; AND GENERATION OF DOCUMENTATION AND USER-FACING RESOURCES TO FACILITATE INVESTIGATOR ACCESS. DR. PURCELL WILL ALSO SUPPORT CROSS-COHORT ANALYTIC INITIATIVES, CONTRIBUTE HARMONIZED DATASETS AND TECHNICAL REPORTS, PARTICIPATE IN CONSORTIUM GOVERNANCE AND MPI COORDINATION MEETINGS, ASSIST WITH TRAINING AND USER SUPPORT ACTIVITIES, AND CONTRIBUTE TO PUBLICATIONS AND NIH PROGRESS REPORTING. WORK WILL BE CONDUCTED CONTINUOUSLY THROUGHOUT THE PROJECT PERIOD IN CLOSE COORDINATION WITH DR. REDLINE AND OTHER NSRR STAFF, WITH DELIVERABLES ALIGNED TO ANNUAL REPORTING MILESTONES AND DATASET RELEASE SCHEDULES.”

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.